Credit Suisse analyst Alethia Young lowered estimates and her price target on Gilead Sciences (NASDAQ: GILD) to $115.00 (from $120.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Jefferies Remains Sidelined on Gilead Sciences (GILD) Following 2Q - PT to $93 July 26, 2016 9:15 AM Gilead Sciences (GILD) PT Bumped to $98 at BMO Capital Posts Q2, Remains SidelinedJuly 26, 2016 8:26 AM Gilead Sciences (GILD) PT Lowered to $108 at Piper JaffrayJuly 26, 2016 8:10 AM Needham & Company Downgrades Gilead Sciences (GILD) to HoldJuly 26, 2016 7:00 AM Gilead Sciences (GILD): Lower Revenue Guidance Highlights Concerns - BairdJuly 26, 2016 6:16 AM Gilead Sciences (GILD) Tops Q2 EPS by 6cJuly 25, 2016 4:09 PM Gilead Sciences Announces Second Quarter 2016 Financial ResultsJuly 25, 2016 4:08 PM